ArticleThoracic cancer2025

First-Line Immune-Combination Therapy for Driver Gene-Negative NSCLC With Brain Metastases: Real-World Outcomes.

Mengxing You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.